Trevi Therapeutics, Inc. (TRVI) earnings

TRVI earnings moved a median of +0.61% by the close. Quarterly and annual TRVI reports and results, each read against the price at its own news timestamp. Back to the TRVI overview →

28 measured TRVI earnings events.

Where these TRVI earnings landedvs 28 measured TRVI earnings reactions
TRVI earningsMiddle 50% · -3.32% to +1.54%Zero: 0.00%Median: +0.61%Median +0.61%-5.00%0+5.00%
Middle 50% of TRVI earnings reactions-3.32% to +1.54%
Median reaction (to close)+0.61%
Measured reactions28
Point-in-time · zero look-ahead

Half of the 28 TRVI earnings events with a measured close landed between -3.32% and +1.54%; 57% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Trevi Therapeutics, Inc. For: Sep 30SEC filing · Form 10-Q+4.60%+5.59%
Trevi Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business UpdatesPress release+4.60%+5.59%
Trevi Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 9, 2026Press release+1.23%+0.36%
Form 10-Q Trevi Therapeutics, Inc. For: Jun 30SEC filing · Form 10-Q-3.69%-3.89%
Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business UpdatesPress release-3.69%-3.89%
Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026Press release-2.22%-1.30%
Form 10-Q Trevi Therapeutics, Inc. For: Mar 31SEC filing · Form 10-Q+0.14%+0.85%
Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business UpdatesPress release+0.14%+0.85%
Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026Press release+0.33%+1.10%
Form 10-K Trevi Therapeutics, Inc. For: Dec 31SEC filing · Form 10-K-6.49%-9.87%
Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025Press release+0.09%+0.09%
Form 10-Q Trevi Therapeutics, Inc. For: Jun 30SEC filing · Form 10-Q-0.69%+2.91%
Trevi Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business UpdatesPress release-0.69%+2.91%
Trevi Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 7, 2025Press release+0.54%-1.08%
Form 10-Q Trevi Therapeutics, Inc. For: Mar 31SEC filing · Form 10-Q-6.62%-7.43%
Trevi Therapeutics Reports First Quarter 2025 Financial Results and Provides Business UpdatesPress release-6.62%-7.43%
Trevi Therapeutics to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 8, 2025Press release+2.17%+1.30%
Form 10-K Trevi Therapeutics, Inc. For: Dec 31SEC filing · Form 10-K-3.15%-2.44%
Form 10-Q Trevi Therapeutics, Inc. For: Sep 30SEC filing · Form 10-Q+2.25%-6.15%
Trevi Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business UpdatesPress release+2.25%-6.15%
Trevi Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on November 6, 2024Press release-1.97%-3.13%
Form 10-Q Trevi Therapeutics, Inc. For: Jun 30SEC filing · Form 10-Q+0.00%+1.42%
Trevi Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Reaffirming Clinical Trial GuidancePress release+0.00%+1.42%
Trevi Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 8, 2024Press release+0.00%-2.52%
Form 10-Q Trevi Therapeutics, Inc. For: Mar 31SEC filing · Form 10-Q+2.15%+1.54%
Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesPress release+2.15%+1.54%
Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024Press release+0.00%+4.15%
Form 10-K Trevi Therapeutics, Inc. For: Dec 31SEC filing · Form 10-K-3.17%+6.63%
That’s how TRVI usually reacts to earnings — get an email when it moves on news →
Keep exploring

More TRVI: analyst actions → · SEC filings → · TRVI overview →